|
|
|
|
||
I Guess At Where We AreI guess we (Galena Long Shareholder), have another extremely long wait in front of us. PRESENT trial is terminated. GALE-401 will be the next compound to be tested starting in 2017 sometimeGALE-301/302 will also move forward at some point. Good news is cash burn will be down. It looks like the Roche Herceptin trial is the wild card here. Thoughts? |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
276 | Re: I Guess At Where We Are | Joenobody06 | 2 | 8/11/2016 12:06:25 AM |